ArticleBMC pulmonary medicine2025
Asthma risk: the inseparable synergy of obesity and metabolism.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundObesity is a risk factor for asthma, but heterogeneity remains. The relationship between different metabolic obesity phenotypes and asthma has not been previously studied.
methodsWe used data from the National Health and Nutrition Examination Survey (NHANES), including a total of 50,544 participants. We compared the nationally weighted prevalence of asthma across different obesity statuses, metabolic conditions, and their combined states, and estimated asthma risk. Patients with asthma were identified through questionnaire data. Weighted chi-square tests were used to compare asthma prevalence between groups. Multivariable weighted logistic regression analyses were used to estimate asthma risk.
resultsIn the total population, obesity (OR = 1.32, P < 0.001) and hypertension (OR = 1.19, P < 0.001) were risk factors for asthma, while hyperglycemia (OR = 1.09, P = 0.062) and dyslipidemia (OR = 0.96, P = 0.254) was not significantly associated with higher asthma risk. Compared to metabolically healthy non-obese individuals, metabolically healthy obese individuals had a higher risk of asthma. Furthermore, when obesity was combined with two or more metabolic risk factors, the risk of asthma was higher by 39% (OR = 1.39, P < 0.001). This effect was more pronounced in females(OR = 1.52 in females vs OR = 1.22 in females, both P < 0.05). Further analysis revealed that, in the total population, obesity combined with isolated hypertension was significantly associated with higher risk of asthma (OR = 1.49, P = 0.001). Moreover, among females, obesity combined with isolated hyperglycemia, hypertension or dyslipidemia was all associated with higher risk of asthma.
conclusionBoth obesity and metabolic abnormalities independently increase asthma risk, and their combined effects pose an even greater threat, particularly among females. These findings highlight the importance of simultaneously addressing both obesity and metabolic abnormalities to reduce asthma risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.